The aim of the paper was to evaluate and determine the duration of the hospital treatment of patients with cataract. Materials and methods of the investigation. 629 case histories were analyzed and 60 patients’ forms were also analyzed. The assessment of case histories was done according to the scheme: sex, age, the stage of cataract, the duration of hospital treatment, the cause of treatment which lasts more than 1 day (postoperative complication, treatment of concomitant eye diseases, patient’s desire), the type of complication. 60 surveyed patients with cataract required surgical treatment in order to work out the model of the duration of hospital treatment. The questionnaire contained several questions, which answers allow evaluating the social status of patients, somatic and optic status, peculiarities of the main disease and also the duration at the hospital after the operation. Results. It has been demonstrated that patient’s age, his or her financial status, the number of concomitant somatic and eye diseases are the main peculiarities for the prognosis for long-lasting stay at hospital after surgical treatment. Undetermined logics was used to create the model of prognosis of the duration of hospital treatment based on еру results of patients’ questionnaire, the method of clustering was used to receive undetermined rules. Conclusions. Ophthalmologic status of the patient, the presence of concomitant eye diseases, such as myopia alta, glaucoma, diseases of retina, and optic nerve and concomitant somatic disease play an important role in the choice of the type of treatment. The most informative indices for hospital treatment of patients with cataract after surgery are patient’s age, his/her financial status, the number of concomitant somatic and eye diseases.
Today, around 50 million people worldwide suffer from cataracts, more than a half of them need surgical treatment. High prevalence of this pathology in Ukraine, the need to improve the provision of ophthalmic care to patients, and the reform of the health care system have made the research relevant. Concomitant diseases and special conditions of the eye increase the risk of intra− and postoperative complications, worsen the functional parameters of patients after surgery. In order to develop a unified approach to the treatment of complicated cataracts based on diagnostically related groups of patients, a retrospective analysis of case histories of patients with different variants of complications related to the condition of the lens itself, its ligament apparatus and other structures of the eye was conducted. In each case, the surgeon has to choose the appropriate modification of cataract phacoemulsification surgery. The study proposed the classification of cataract phacoemulsification modifications on the basis of the techniques and the sequence of operation stages, taking into account the classification of the degrees of turbidity of the lens, proposed by L. Buratto. It has been noted that in complicated cases, according to the indications of the patient, surgery may be performed on several modifications of cataract phacoemulsification. The developed classification made it possible to generalize the various variants of pathology and greatly facilitate the choice of tactics of surgical treatment in complicated cataracts. It can be used not only for practical application, but also for improving the qualification of trained professionals. The prospect of further research is to identify contraindications for outpatient treatment of the patients with complicated cataracts. Key words: cataract complication, classification of phacoemulsification modifications, diagnostically related groups.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.